Developments in Glaucoma Surgery

Size: px
Start display at page:

Download "Developments in Glaucoma Surgery"

Transcription

1 Developments in Glaucoma Surgery Marlene R. Moster, MD Professor of Ophthalmology Thomas Jefferson University School of Medicine Wills Eye Hospital Philadelphia, PA

2 When is surgery indicated? Poor control Poor compliance Medication side effects

3 Glaucoma Surgery Filtering Surgery Trabeculectomy Filter with anti-fibroblastic agents Implants Molteno, Ahmed, Baervelt New filtering procedures

4 Trabeculectomy Introduced by Cairns in 1968 Success improved with the adjunctive use of an antimetabolite (5FU, MMC) Complications: bleb leaks, bleb-related infections

5 Risk Factors Associated with Bleb Failure Previous surgery filter, cataract African American Young age Uveitis Angle recession Secondary angle closure Neovascularization Aphakia

6 Bleb Failure What causes the majority of problems? Successful trab = filtration Filtration = fistula Fistula = bleb Bleb = PROBLEMS

7 Bleb Failure 1) Large cystic blebs 2) Infected blebs 3)Bleb dysthesia dreaded patient

8 Large Cystic Blebs

9 Trabeculectomy What Do Antimetabolites Do Decrease proliferation and contractile movement of fibroblasts 5-fluorouracil (5-FU) Mitomycin C 100x more potent than 5-FU

10 Trabeculectomy with MMC Changes in surgical technique Lower dosage of MMC Diffuse MMC application Fornix-based conjunctival flap Diffuse, low-lying bleb Fewer bleb leaks Lower rate of bleb infections Improved patient comfort Jones E, et al. Curr Opin Ophthalmol 2005;16: Wells AP, et al. Ophthalmology 2003;110:

11 Trabeculectomy with MMC Fornix-based flap Diffuse application of MMC Limbus-based flap Localized application of MMC Courtesy of Dr. Peng Khaw

12 Glaucoma Surgical Directions Glaucoma Drainage Implants New Surgical Approaches Trabecutome Excimer laser trabeculoplasty Express implant Glaukos trabecular bypass stent Eyepass glaucoma implant Canaloplasty Gold micro shunt

13 Glaucoma Drainage Implants Introduced by Molteno in 1968 Tube shunts aqueous from AC or PC to episcleral plate Design differences Size, shape, and material of plate Valved and nonvalved Complications: diplopia, tube erosion

14 Ablation of TM and inner wall of Schlemm s canal Ab interno approach Handpiece has I/A port and electrocautery tip FDA approved Trabectome Courtesy of NeoMedix Corp.

15 Trabectome Minckler DS, et al. Ophthalmology 2005;112:

16 Express Implant Stainless steel device with internal diameter μm Shunts aqueous from AC to subconjunctival space Avoids need for sclerostomy and PI Placement under a scleral flap is necessary to avoid hypotony and erosion FDA approved Courtesy of Optonol Ltd.

17 Express Implant Modified guarded full thickness procedures

18 Express Implant Maris PJG, et al. J Glaucoma 2007;16:14-19.

19 ADVANTAGES Express Implant IOP CONTROL SIMILAR TO TRABS MARZETTE ET AL -08) NO PI SO LESS INFLAMATION /BLEEDING REGULAR OSTEUM SIZE LESS HYPOTONY MARZETTE ET AL -08 DISADVANTAGES MOVES WITH MRI GEFFEN ET AL ARVO-08 RECENT REPORTS REGARDING EXTRUSION EXPENSIVE TRAB BLEB PRODUCED

20 Glaukos Trabecular Bypass Micro-Stent Titanium, snorkel-shaped device Inserted into Schlemm s canal using an ab interno approach Not FDA approved Courtesy of Glaukos Corp.

21 Eyepass Glaucoma Implant Silicone Y-shaped tube Proximal end inserted into AC and each arm into Schlemm s canal via an ab externo approach Shunts aqueous into Schlemm s canal Not FDA approved Courtesy of GMP Vision Solutions Inc.

22 Microcatheter with fiber optic tip is passed through Schlemm s canal via ab externo approach Healon GV is used to dilate canal 10-prolene keeps canal open FDA approved Canaloplasty Courtesy of iscience Interventional Corp.

23 Canaloplasty All Patients (n = 94)

24 Gold-Micro Shunt 24-karat flat plate Microchannels control flow from AC to suprachoroidal space Titanium sapphire laser used to open 1 or more channels to increase flow Courtesy of SOLX, Inc.

25 Gold-Micro Shunt 16-30% hyphema rate

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma)

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma) Protocol Aqueous Shunts and Stents for Glaucoma (90321) (Formerly Aqueous Shunts for Glaucoma) Medical Benefit Effective Date: 01/01/13 Next Review Date: 01/14 Preauthorization* No Review Dates: 03/10,

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/14 Next Review Date: 01/15 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14

More information

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy.

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy. Medical Policy Title: Aqueous Shunts and ARBenefits Approval: 10/26/2011 Devices for Glaucoma Effective Date: 01/01/2012 Document: ARB0168 Revision Date: Code(s): 66174, Transluminal dilation of aqueous

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Aqueous Shunts and Devices for Glaucoma File Name: Origination: Last CAP Review: Next CAP Review: Last Review: aqueous_shunts_and_devices_for_glaucoma 3/2010 6/2017 6/2018 6/2017

More information

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures Optometrist's Guide to Glaucoma Surgery Anthony DeWilde, OD FAAO I have no financial disclosures 1 2 Goals Glaucoma Philosophy Glaucoma can be a visually debilitating disease. How glaucoma surgery works

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2014 Origination: 9/2008 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110 Subject Index Ab externo Schlemm canal surgery, see Canaloplasty, Viscocanalostomy Ab interno Schlemm canal surgery, see istent, Trabectome Adjustable sutures 14, 15 AGV glaucoma drainage implants 43,

More information

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK Financial Disclosure None to be Declared Presentation overview Glaucoma Surgical History Complications of trabeculectomy Express Device Specifications Surgical Steps Clinical advantages, indications and

More information

Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016

Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016 Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016 Financial Disclosures Surgical Glaucoma History Glaucoma Surgery Trends 1994-2012

More information

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY?

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY? XEN GEL STENT OMAHA AND LINCOLN EYE AND LASER INSTITUTES MARK R. YOUNG, M.D. April 7, 2018 QUESTION: Why are we looking for alternatives to current glaucoma treatment? Look at current surgical glaucoma

More information

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO Rapid Fire MIGS A Modern Solution to a Complex Problem Course Description: Minimally (or Micro-) Invasive Glaucoma Surgeries, or MIGS, are an increasingly popular treatment modality in the management of

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Viscocanalostomy and Canaloplasty File Name: Origination: Last CAP Review: Next CAP Review: Last Review: viscocanalostomy_and_canaloplasty 11/2011 6/2017 6/2018 6/2017 Description

More information

Viscocanalostomy and Canaloplasty. Description. Section: Other Effective Date: July 15, 2015

Viscocanalostomy and Canaloplasty. Description. Section: Other Effective Date: July 15, 2015 Subject: Viscocanalostomy and Canaloplasty Page: 1 of 10 Last Review Status/Date: June 2015 Viscocanalostomy and Canaloplasty Description Glaucoma surgery is intended to reduce intraocular pressure (IOP)

More information

Aqueous Shunts and Stents for Glaucoma. Description

Aqueous Shunts and Stents for Glaucoma. Description Subject: Aqueous Shunts and Stents for Glaucoma Page: 1 of 13 Last Review Status/Date: June 2015 Aqueous Shunts and Stents for Glaucoma Description Glaucoma is not a single entity; there are many subcategories

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community.

More information

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma.

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma. Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/15 Next Review Date: 11/18 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14,

More information

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste Minimally-Invasive Surgery & Other new devices -a Foretaste Keith Barton Consultant Ophthalmologist Moorfields Eye Hospital, London Market capitalisation of new glaucoma surgical device companies >$500m

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 8/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery

New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery Joseph L Lin 1 and Hylton R Mayer 2 1. Ophthalmology Resident; 2. Assistant Professor, Department of Ophthalmology and Visual

More information

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Glaucoma Surgical Treatments Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Disclosures Murray Fingeret Consultant Bausch & Lomb, Alcon, Allergan Justin Schweitzer Allergan, Glaukos, Bausch and

More information

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER Original Issue Date (Created): October 1, 2010 Most Recent Review Date (Revised): January 28, 2014 Effective Date: May 1, 2014 I. POLICY Insertion of aqueous shunts approved by the U.S. Food and Drug Administration

More information

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision 9.03.21 Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision Effective Date January 30, 2015 Original Policy Date January 30, 2015 Next Review Date January 2016 Description Glaucoma

More information

Managing & Avoiding Post-Op Complications in Tube Surgeries

Managing & Avoiding Post-Op Complications in Tube Surgeries Managing & Avoiding Post-Op Complications in Tube Surgeries K. Sheng Lim St. Thomas Hospital, London shenglim@gmail.com Current GDD Molteno 1969 Baerveldt 1990 Ahmed 1993 Current GDD GDD Plate Material

More information

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL)

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL) MIGS: How did we get here? GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: 55570-GL) John Gelvin, O.D., F.A.A.O. MOYES EYE CENTER Kansas City, Missouri jgelvin@moyeseye.com 1. Tube vs Trabeculectomy?

More information

Viscocanalostomy and Canaloplasty

Viscocanalostomy and Canaloplasty Viscocanalostomy and Canaloplasty Policy Number: 9.03.26 Last Review: 9/2014 Origination: 9/2012 Next Review: 9/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for

More information

Novel Glaucoma Procedures

Novel Glaucoma Procedures Ophthalmic Technology Assessment Novel Glaucoma Procedures A Report by the American Academy of Ophthalmology Brian A. Francis, MD, 1 Kuldev Singh, MD, MPH, 2 Shan C. Lin, MD, 3 Elizabeth Hodapp, MD, 4

More information

AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE

AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE WHITEPAPER AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE AB-INTERNO CANALOPLASTY: TREATMENT STEPS 12-MONTH CASE SERIES REVIEW ABiC Canaloplasty performed with an

More information

Microinvasive surgical

Microinvasive surgical Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices BY ROD MCNEIL Microinvasive surgical approaches to primary openangle glaucoma (POAG) offer minimally traumatic

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): June 4, 2013 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY PAGE: 1 OF: 8 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery

Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery AB-INTERNO CANALOPLASTY: TREATMENT STEPS Primary open-angle glaucoma (POAG) is a sightthreatening condition caused by suboptimal

More information

Aqueous Shunts for the Treatment of Glaucoma

Aqueous Shunts for the Treatment of Glaucoma TITLE: Aqueous Shunts for the Treatment of Glaucoma AUTHOR: Jeffrey A. Tice, MD Assistant Professor of Medicine Division of General Internal Medicine Department of Medicine University of California San

More information

Chirurgia del Glaucoma: perché tecniche differenti portano a risultati diversi sulla pressione intraoculare

Chirurgia del Glaucoma: perché tecniche differenti portano a risultati diversi sulla pressione intraoculare Università di Verona Dipartimento di Neuroscienze, Biomedicina e Movimento Sezione di Oftalmologia Scuola di Specializzazione in Oftalmologia Direttore: Prof. Giorgio Marchini AOUI di Verona Dipart. Assist.

More information

John A. McGreal Jr., O.D. Missouri Eye Associates Old Ballas Rd. St. Louis, MO FAX

John A. McGreal Jr., O.D. Missouri Eye Associates Old Ballas Rd. St. Louis, MO FAX John A. McGreal Jr., O.D. Missouri Eye Associates 11710 Old Ballas Rd. St. Louis, MO. 63141 314.569.2020 314.569.1596 FAX jamod1@aol.com Glaucoma Evolution Glaucoma Evaluation is Transforming In the past,

More information

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma Financial Disclosures for Mitch Ibach OD, FAAO MIGs in the BIGs A professional level understanding of MIGs Glaukos Alcon Equinox LLC. Mitch Ibach OD, FAAO Vance Thompson Vision Human Cost of Glaucoma WHY

More information

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy File name: Aqueous Shunts and Stents for Glaucoma File code: UM.SURG.18 Origination: New Policy Last Review: 06/2017 Next Review: 06/2018

More information

Viscocanalostomy and Canaloplasty

Viscocanalostomy and Canaloplasty Viscocanalostomy and Canaloplasty Policy Number: 9.03.26 Last Review: 9/2017 Origination: 9/2012 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for

More information

WGA. The Global Glaucoma Network

WGA. The Global Glaucoma Network The Global Glaucoma Network Fort Lauderdale April 30, 2005 Indications for Surgery 1. The decision for surgery should consider the risk/benefit ratio. Note: Although a lower IOP is generally considered

More information

TRABECULECTOMY. Dr. Sandra M. Johnson, MD

TRABECULECTOMY. Dr. Sandra M. Johnson, MD TRABECULECTOMY Dr. Sandra M. Johnson, MD FILTRATION OPTIONS Trabeculotomy, Schlemn s canal, internal Deep Non-penetrating Sclerectomy filtering to a scleral lake, or viscocanulostomy Trabeculectomy shunting

More information

CHARTING THE NEW COURSE FOR MIGS

CHARTING THE NEW COURSE FOR MIGS CHARTING THE NEW COURSE FOR MIGS SEE WHAT S ON THE HORIZON CyPass Micro-Stent the next wave in micro-invasive glaucoma surgery. MICRO-INVASIVE GLAUCOMA SURGERY (MIGS) OFFERS A REVOLUTIONARY APPROACH TO

More information

sad EFFECTIVE DATE: POLICY LAST UPDATED:

sad EFFECTIVE DATE: POLICY LAST UPDATED: Medical Coverage Policy Aqueous Shunts and Stents for Glaucoma sad EFFECTIVE DATE: 08 19 2014 POLICY LAST UPDATED: 09 18 2018 OVERVIEW Glaucoma surgery is intended to reduce intraocular pressure (IOP)

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Last Review: September 2016 Next Review: September 2017 Related Policies 9.03.06 Opthalmalologic Techniques for Evaluating Glaucoma 9.03.26 Viscocanalostomy and Canaloplasty Aqueous

More information

Viscocanalostomy and Canaloplasty

Viscocanalostomy and Canaloplasty Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3%

The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3% The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3% of our population age > 40 have glaucoma In the past:

More information

Keeping Current in Glaucoma Surgery

Keeping Current in Glaucoma Surgery Keeping Current in Glaucoma Surgery #51596-GL COPE April 2018 Ilya Rozenbaum, MD Matossian Eye Associates Financial Disclosures Alcon Allergan B+L Glaukos Human Cost of Glaucoma Glaucoma is the second

More information

Anterior Segment Cataract and Refractive

Anterior Segment Cataract and Refractive Cataract Surgery in the Glaucoma Patient Brooks J Poley, MD, 1 Richard L Lindstrom, MD, 2 Thomas W Samuelson, MD 3 and Richard R Schulze, Jr, MPhil, MD 4 1. Retired Clinical Associate Professor; 2. Adjunct

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Oxford Clinical Policy Policy Number: VISION 023.20 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Commercial Medical Policy Policy Number: OPT014 Effective Date: May 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS... 1 COVERAGE

More information

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar Tubes, Ties and Videotape: Surgical Video of Glaucoma Implants and Financial Disclosure I have no financial interests or relationships to disclose. Herbert P. Fechter MD, PE Eye Physicians and Surgeons

More information

PRINCIPLES AND TYPES OF GLAUCOMA SURGERIES

PRINCIPLES AND TYPES OF GLAUCOMA SURGERIES PRINCIPLES AND TYPES OF GLAUCOMA SURGERIES DR.FAISAL ALMOBARAK ASSISTANT PROFESSOR AND CONSULTANT DEPARTMENT OF OPHTHALMOLOGY COLLEGE OF MEDICINE AND KING SAUD UNIVERSITY SAUDI ARABIA INTRODUCTION AQUEOUS

More information

A REVIEW OF MINIMALLY-INVASIVE GLAUCOMA SURGERY (MIGS) Felise May Barte, MD CECOM Symposium 2019

A REVIEW OF MINIMALLY-INVASIVE GLAUCOMA SURGERY (MIGS) Felise May Barte, MD CECOM Symposium 2019 I. Traditional glaucoma surgery A. Trabeculectomy B. Tube Shunt C. Tube versus Trabeculectomy Study Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, Tube Versus Trabeculectomy Study

More information

New options for combined cataract and glaucoma surgery

New options for combined cataract and glaucoma surgery REVIEW C URRENT OPINION New options for combined cataract and glaucoma surgery Donald L. Budenz a and Steven J. Gedde b Purpose of review To review the current literature regarding the effectiveness and

More information

TRABECULECTOMY THE BEST AND WORST CANDIDATES

TRABECULECTOMY THE BEST AND WORST CANDIDATES TRABECULECTOMY THE BEST AND WORST CANDIDATES MICHAEL F. OATS, MD OPHTHALMIC CONSULTANTS OF BOSTON ASCRS 2014 FINANCIAL DISCLOSURES None TRABECULECTOMY Performed for over 100 years Most commonly performed

More information

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas I developed the course material/information independently No relevant financial relationship exists by anyone in control of presentation content

More information

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18 MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES PAGE: 1 OF: 11 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Landmark Tube Trials

Landmark Tube Trials SECTION EDITOR: BARBARA SMIT, MD, PhD Landmark Tube Trials A review of key findings from recent multicenter randomized clinical trials involving tube shunts. BY AMBIKA HOGUET, MD, AND STEVEN J. GEDDE,

More information

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty Subject: Document#: Publish Date: 02/28/2018 Status: Reviewed Last Review Date: 01/25/2018 Description/Scope This document addresses surgical devices used in the treatment of refractory open-angle glaucoma

More information

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA DR.FAISAL ALMOBARAK ASSISTANT PROFESSOR AND CONSULTANT DEPARTMENT OF OPHTHALMOLOGY COLLEGE OF MEDICINE AND KING

More information

Aqueous Shunts and Stents Treatment For Glaucoma

Aqueous Shunts and Stents Treatment For Glaucoma Aqueous Shunts and Stents Treatment For Glaucoma Policy Number: 2015M0059A Effective Date: July 1, 2015 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION 2 Not Available COVERAGE RATIONALE/CLINICAL

More information

Trabeculectomy is the most commonly performed surgery

Trabeculectomy is the most commonly performed surgery ORIGINAL STUDY Standard Trabeculectomy and Ex-PRESS Miniature Glaucoma Shunt: A Comparative Study and Literature Review Elad Moisseiev, MD, Eran Zunz, MD, Rotem Tzur, MD, Shimon Kurtz, MD, and Gabi Shemesh,

More information

Surgical outcomes of Trab and Tube for Uveitic glaucoma - Experience from a Tertiary Institution

Surgical outcomes of Trab and Tube for Uveitic glaucoma - Experience from a Tertiary Institution Surgical outcomes of Trab and Tube for Uveitic glaucoma - Experience from a Tertiary Institution Hye Jin Kwon, George YX Kong, William Tao, Lyndell Lim, Keith R Martin, Cathy Green, Jonathan Ruddle, Jonathan

More information

BrightFocus Foundation is the new name for American Health Assistance Foundation.

BrightFocus Foundation is the new name for American Health Assistance Foundation. In this section, you will find the following: Glaucoma Medications Laser Therapies Conventional Surgical Procedures In the second section, you will find information on how to search for potential treatments

More information

Challenging complications of valve implantation. Salah M Al-Mosallamy MD Assistant professor of ophthalmology 2014

Challenging complications of valve implantation. Salah M Al-Mosallamy MD Assistant professor of ophthalmology 2014 Challenging complications of valve implantation by Salah M Al-Mosallamy MD Assistant professor of ophthalmology 2014 PREDISPOSING FACTORS It is important to consider the case mix for these devices on dealing

More information

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1% We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries

More information

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL FOR THE REDUCTION OF IOP IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA AT THE TIME OF CATARACT SURGERY and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT,

More information

Journal of American Science 2014;10(2)

Journal of American Science 2014;10(2) Outcomes Of Combined Phaco -Trabectome Surgery in Patients with Cataract and Primary Open-angle Glaucoma Mahmoud M Saleh, MD, Abdalla M Elamin, MD and Hassan M Bayoumy, MD AL Azhar university hospital

More information

New Horizons in Glaucoma Devices. Steven Vold MD Vold Vision February 4, 2017

New Horizons in Glaucoma Devices. Steven Vold MD Vold Vision February 4, 2017 1 New Horizons in Glaucoma Devices Steven Vold MD Vold Vision February 4, 2017 2 Financial Disclosures Vold Vision, P.L.L.C BK Ventures Group Company Nature of Affiliation Founder and Chief Executive Office

More information

Implants in glaucoma: a minor review

Implants in glaucoma: a minor review Implants in glaucoma: a minor review Dr. Kumar Ravi, Dr. Prashant Srivastava, Dr. Mayav Movdawalla, Dr. Surajit Sen and Dr. Prerna Kedia Author for Correspondence: Dr. Kumar Ravi, Consultant Introduction

More information

THE ISTENT t TRABECULAR MICRO-BYPASS STENT: A CASE SERIES

THE ISTENT t TRABECULAR MICRO-BYPASS STENT: A CASE SERIES THE ISTENT t TRABECULAR MICRO-BYPASS STENT: A CASE SERIES VANDEWALLE E.*, ZEYEN T.*, STALMANS I.* ABSTRACT Purpose: To evaluate the safety and effectiveness of a trabecular micro-bypass stent, the istent

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Emerging Surgical Procedures for Glaucoma Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 12 References... 13 Effective

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 60 Effective Health Care Program Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment

More information

Morning Report. copyright The University of Colorado. Ashley Laing 09/01/10 Preceptor- Dr. Pantcheva

Morning Report. copyright The University of Colorado. Ashley Laing 09/01/10 Preceptor- Dr. Pantcheva Morning Report Ashley Laing 09/01/10 Preceptor- Dr. Pantcheva Case Presentation CC: Right eye pain and headache HPI: 52 yo Caucasian male Presents to ED with OD pain/redness, decreased vision, headache

More information

Demographics and POAG: Time to Consider Alternative Care Models David S. Friedman, MD, MPH, PhD

Demographics and POAG: Time to Consider Alternative Care Models David S. Friedman, MD, MPH, PhD Demographics and POAG: Time to Consider Alternative Care Models David S. Friedman, MD, MPH, PhD Director, Dana Center for Preventive Ophthalmology Wilmer Eye Institute, Alfred Sommer Professor of Ophthalmology

More information

Glaucoma Surgery Louis B. Cantor, MD Jay C. and Lucile L. Kahn Chair and Professor Director of Glaucoma Service

Glaucoma Surgery Louis B. Cantor, MD Jay C. and Lucile L. Kahn Chair and Professor Director of Glaucoma Service Glaucoma Surgery 2018 Louis B. Cantor, MD Jay C. and Lucile L. Kahn Chair and Professor Director of Glaucoma Service Disclosures Research Support: Allergan, InnFocus, Bausch and Lomb Consultant: Zeiss

More information

Russ Trenary President & CEO.

Russ Trenary President & CEO. Russ Trenary President & CEO www.innfocusinc.com The InnFocus Winning Combination in Glaucoma Lowest IOP in studies IOP data below 14 mmhg with 3 year follow up. FDA requires 2 years max. SIBS material

More information

Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study

Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study Donald L Budenz, MD, MPH; Keith Barton, MD; Steven J Gedde, MD; William J Feuer, MS; Joyce Schiffman, MS; Vital P Costa, MD; David

More information

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD Supplement to CME Activity September/October 2012 Changing the Glaucoma Treatment ParadigM Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD L. Jay Katz, MD Richard A. Lewis, MD Thomas

More information

THE TRABECTOME IS A NOVEL SURGICAL DEVICE USED

THE TRABECTOME IS A NOVEL SURGICAL DEVICE USED Delayed-Onset Symptomatic Hyphema After Ab Interno Trabeculotomy Surgery YACHNA AHUJA, MEHRDAD MALIHI, AND ARTHUR J. SIT PURPOSE: To describe patients who have experienced delayed-onset hyphema after ab

More information

9/25/2018. New Generation Glaucoma Care. Disclosures. Overview

9/25/2018. New Generation Glaucoma Care. Disclosures. Overview New Generation Glaucoma Care MARK MARAMAN, O.D. NOA MEETING KEARNEY, NE OCT 4 TH, 2018 Disclosures I have no financial relationships or conflicts of interest with the manufacturers of any commercial products

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

Review Article Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants

Review Article Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants Journal of Ophthalmology Volume 2013, Article ID 705915, 12 pages http://dx.doi.org/10.1155/2013/705915 Review Article Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants Lívia M. Brandão

More information

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD Supplement to CME Activity January 2013 Changing the Glaucoma Treatment ParadigM Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD Richard L. Lindstrom, MD Thomas W. Samuelson,

More information

Trabeculectomy - A Short Term Follow-up

Trabeculectomy - A Short Term Follow-up Trabeculectomy - A Short Term Follow-up Pages with reference to book, From 193 To 196 K.S. Hasan, G. Rabbani, S. Hashmani, M.M. Hasan ( Department of Ophthalmology Civil Hospital and Dow Medical College.

More information

Scope Surgical Management of Co-existing Glaucoma and Cataract

Scope Surgical Management of Co-existing Glaucoma and Cataract Scope Surgical Management of Co-existing Glaucoma and Cataract < single image > 4.3cm x 5.5cm Desmond QUEK Jocelyn CHUA Daniel SU What are the options? How is it done? What to look out for and how to get

More information

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing Glaucoma How is Glaucoma Diagnosed? Glaucoma Testing There is no single test for glaucoma. The diagnosis is made by evaluating the patient from a number of perspectives, using specialized instruments.

More information

Cronicon EC OPHTHALMOLOGY. Research Article Trephine Assisted Trabeculectomy Technique. Idrees* Introduction

Cronicon EC OPHTHALMOLOGY. Research Article Trephine Assisted Trabeculectomy Technique. Idrees* Introduction Cronicon OPEN ACCESS EC OPHTHALMOLOGY Research Article Idrees* Al Dara Hospital and Medical Center at Riyadh, Saudi Arabia *Corresponding Author: Dr Idrees, Al Dara Hospital and Medical Center at Riyadh,

More information

Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results

Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results Youssef Dib Bustros et al ORIGINAL REASEARCH 10.5005/jp-journals-10028-1221 Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results 1 Youssef Dib Bustros, 2

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): 10/1/2010 Most Recent Review Date (Revised): 8/29/2018 Effective Date: 11/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary

More information

THE CURRENT TREATMENT OF GLAUCOMA IS DIrected

THE CURRENT TREATMENT OF GLAUCOMA IS DIrected Three-Year Follow-up of the Tube Versus Trabeculectomy Study STEVEN J. GEDDE, JOYCE C. SCHIFFMAN, WILLIAM J. FEUER, LEON W. HERNDON, JAMES D. BRANDT, AND DONALD L. BUDENZ, ON BEHALF OF THE TUBE VERSUS

More information

Update on Tube-Shunt Procedures for Glaucoma

Update on Tube-Shunt Procedures for Glaucoma Chapter Update on Tube-Shunt Procedures for Glaucoma Jeffrey Freedman Core Messages Bleb formation depends on proinflammatory substances in the aqueous, as well as tissue reaction, both of which can be

More information

Trabeculectomy A Review and 2 Year Follow Up

Trabeculectomy A Review and 2 Year Follow Up ORIGINAL ARTICLE Trabeculectomy A Review and 2 Year Follow Up F Jaais, (MRCOphth) Department of Ophthalmology, University Malaya Medical Center, Faculty of Medicine, 50603 Kuala Lumpur Summary This study

More information

Micro-invasive glaucoma surgery: current perspectives and future directions

Micro-invasive glaucoma surgery: current perspectives and future directions REVIEW C URRENT OPINION Micro-invasive glaucoma surgery: current perspectives and future directions Hady Saheb a,b and Iqbal Ike K. Ahmed b,c Purpose of review There is an increasing interest and availability

More information

CLASS-y Laser Treats Glaucoma

CLASS-y Laser Treats Glaucoma Article # 404 Comments About the Author Released: Author: Category: March 12th, 2014 Issue #0314 Ehud Assia Feature S S S S S CLASS-y Laser Treats Glaucoma Transforming complex, invasive and risky glaucoma

More information

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos Cataract-Glaucoma Preoperative considerations Dimitrios Mikropoulos Cataract surgery alone Trabeculectomy alone Combined surgery The cataract is visually significant, and the glaucoma is well controlled

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary

More information

Glaucoma is an important cause of blindness worldwide,

Glaucoma is an important cause of blindness worldwide, Ex-PRESS implantation versus trabeculectomy in Chinese patients with POAG: fellow eye pilot study Wei Wang, Min-Wen Zhou, Wen-Bin Huang, Xin-Bo Gao, Xiu-Lan Zhang Clinical Research Zhongshan Ophthalmic

More information

Humanity s Vision Is Our Focus. The Ahmed Glaucoma Valve

Humanity s Vision Is Our Focus. The Ahmed Glaucoma Valve Humanity s Vision Is Our Focus The Ahmed Glaucoma Valve Dr. A. Mateen Ahmed President - New World Medical New World Medical is a high tech medical device company whose goal is to help humanity lead a better

More information